Sign In
Buy MDT
$81.93
+3.98 (+5.11%)
At Close: Jun 04, 2026
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
02:27pm, Monday, 03'rd Jun 2024
Finding overlooked stocks (worth investing in) is tough in today's market. While you can screen for micro-caps, pink sheet stocks, and similar speculative investments, most of the best blue-chip and l
Medtronic announces closing of public offering of €3.0 billion of senior notes
06:57am, Monday, 03'rd Jun 2024
DUBLIN , June 3, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the
Beat the Heat: 3 Stocks to Buy Before the Summer Slowdown Sets In
06:00am, Monday, 03'rd Jun 2024
The summer doldrums are almost upon us. June is absolutely the worst month in which to invest, no matter the market index.
Is Medtronic Stock a Buy?
03:40am, Saturday, 01'st Jun 2024
Medtronic's growth rate has been showing signs of improvement. The company recently announced it would be raising its dividend for the 47th consecutive year.
Watch These 5 Stocks That Recently Hiked Dividends
09:11am, Friday, 31'st May 2024
Investors may keep a tab on stocks like HLNE, RL, SPTN, EQH and MDT, which have lately hiked their dividend payments.
Medtronic Stock Is a Sell, According to 1 Wall Street Analyst
04:13pm, Thursday, 30'th May 2024
Medtronic exceeded quarterly forecasts last week, but its stock got punished anyway. Shares cost nearly 30x earnings, but those earnings are growing painfully slowly.
Medtronic announces pricing of €3.0 billion of senior notes
05:10pm, Wednesday, 29'th May 2024
DUBLIN , May 29, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of �
The 3 Best MedTech Stocks to Buy Now: May 2024
02:30pm, Wednesday, 29'th May 2024
In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity
My Best Dividend Aristocrats For June 2024
11:37pm, Tuesday, 28'th May 2024
The ProShares S&P 500 Dividend Aristocrats ETF hits its first speed bump in April, dropping by 4.69%. Some of this loss has been recovered in May. I present 3 strategies that can theoretically beat th
If You Can Only Buy One Dividend Stock in May, It Better Be One of These 3 Names
02:38pm, Tuesday, 28'th May 2024
Dividend stocks are making a comeback in portfolios after a period where higher interest rates made fixed-income options more attractive to income investors. As these investors return to dividend stoc
Going Beyond Morningstar's 10 Best Dividend Stocks List
08:55pm, Monday, 27'th May 2024
Morningstar published their 10 Best Dividend Stocks, which are undervalued blue-chip stocks with reliable dividends. The article analyzes the valuation and estimated future total return of each stock,
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
12:46pm, Monday, 27'th May 2024
Earlier, the Federal Reserve stood poised to cut the benchmark interest rate, which boded well for reliable dividend stocks. Essentially, Uncle Sam's high yields wouldn't compete with the passive inco
Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
10:18am, Monday, 27'th May 2024
Medtronic's fair price estimate is $142.20, indicating a 73.3% upside from $82.07, with potential annual returns of 28.8% through 2029. FQ4 2024 earnings exceeded expectations with an EPS of $1.46 and
Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?
04:51am, Sunday, 26'th May 2024
Medtronic stock reacted negatively to an earnings report that many Wall Street analysts found encouraging. Wells Fargo raised its price target for Medtronic to $105 per share.
Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial
11:01am, Friday, 24'th May 2024
Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.
